TAE Life Sciences
Pre-clinicalTAE Life Sciences is revolutionizing cancer research through our proprietary Boron Neutron Capture Therapy (BNCT) technology. Learn about how we seek to provide this promising treatment to patients with even the most difficult malignancies.
About
TAE Life Sciences is revolutionizing cancer research through our proprietary Boron Neutron Capture Therapy (BNCT) technology. Learn about how we seek to provide this promising treatment to patients with even the most difficult malignancies.
Funding History
1Total raised: $30M
Series A$30MFidelity Management & Research CompanyMar 15, 2021
Company Info
TypePrivate
LocationUnited States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile